Preoperative evaluation of thyroid nodules with 18FDG-PET/CT

Surgery

Volumn 138, Issue 6, 2005, Pages 1166-1175

  Mitchell, Jamie C ^a   Grant, Frederick ^a   Evenson, Amy R ^a   Parker, J A ^a   Hasselgren, Per Olof ^a   Parangi, Sareh ^a,b   Kebebew, Electron ^c   Haigh, Philip I ^c   Heller, Keith S ^c   Rosen, Irving B ^c   Shaha, Ashok R ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CELL DIFFERENTIATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STANDARDIZATION; THYROID NODULE;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THYROID NODULE; THYROIDECTOMY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 29144461539     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.08.031     Document Type: Article

References (26)

1. K.C. Suen, and N.F. Quenville Fine needle aspiration biopsy of the thyroid gland: A study of 304 cases J Clin Pathol 36 9 1983 1036 1045
2. H. Gharib, and J.R. Goellner Fine-needle aspiration biopsy of the thyroid: an appraisal Ann Intern Med 118 4 1993 282 289
3. R.J. Silver, and S. Parangi Management of thyroid incidentalomas Surg Clin North Am 84 3 2004 907 919
4. E. Papini, R. Guglielmi, and A. Bianchini Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features J Clin Endocrinol Metab 87 5 2002 1941 1946
5. L. Leenhardt, G. Hejblum, and B. Franc Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules J Clin Endocrinol Metab 84 1 Jan 1999 24 28
6. D.J. Finley, B. Zhu, and C.B. Barden Discrimination of benign and malignant thyroid nodules by molecular profiling Ann Surg 240 3 2004 425 436 discussion 436-7
7. C. Mazzanti, M.A. Zeiger, and N.G. Costouros Using gene expression profiling to differentiate benign versus malignant thyroid tumors Cancer Res 64 8 2004 2898 2903
8. R. Chisin, and H.A. Macapinlac The indications of FDG-PET in neck oncology Radiol Clin North Am 38 5 2000 999 1012
9. S.M. Larson, and R. Robbins Positron emission tomography in thyroid cancer management Semin Roentgenol 37 2 2002 169 174
10. P. Lind, G. Kumnig, and S. Matschnig The role of F-18FDG PET in thyroid cancer Acta Med Austriaca 27 2 2000 38 41
11. E. Kresnik, H.J. Gallowitsch, and P. Mikosch Fluorine-18- fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area Surgery 133 3 2003 294 299
12. A.D. Bloom, L.P. Adler, and J.M. Shuck Determination of malignancy of thyroid nodules with positron emission tomography Surgery 114 4 1993 728 734 discussion 734-5
13. H. Uematsu, N. Sadato, and T. Ohtsubo Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors J Nucl Med 39 3 1998 453 459
14. A. Bockisch, K. Brandt-Mainz, and R. Gorges Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner Acta Med Austriaca 30 1 2003 22 25
15. E. Goshen, O. Cohen, and G. Rotenberg The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma Nucl Med Commun 24 9 2003 959 961
16. L. Hooft, O.S. Hoekstra, and W. Deville Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer J Clin Endocrinol Metab 86 8 2001 3779 3786
17. M.R. Castro, and H. Gharib Thyroid fine-needle aspiration biopsy: Progress, practice, and pitfalls Endocr Pract 9 2 2003 128 136
18. K.W. Kang, S.K. Kim, and H.S. Kang Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects J Clin Endocrinol Metab 88 9 2003 4100 4104
19. D.J. Finley, B. Zhu, and T.J. Fahey 3rd Molecular analysis of Hurthle cell neoplasms by gene profiling Surgery 136 6 2004 1160 1168
20. M.L. Carcangiu, S. Bianchi, and D. Savino Follicular Hurthle cell tumors of the thyroid gland Cancer 68 9 1991 1944 1953
21. A. Stojadinovic, A. Hoos, and R.A. Ghossein Hurthle cell carcinoma: a 60-year experience Ann Surg Oncol 9 2 2002 197 203
22. N.W. Thompson, E.L. Dunn, and J.G. Batsakis Hurthle cell lesions of the thyroid gland Surg Gynecol Obstet 139 4 1974 555 560
23. A. Pisanu, L. Sias, and A. Uccheddu Factors predicting malignancy of Hurthle cell tumors of the thyroid: influence on surgical treatment World J Surg 28 8 2004 761 765
24. K. Matsuzu, F. Segade, and U. Matsuzu Differential expression of glucose transporters in normal and pathologic thyroid tissue Thyroid 14 10 2004 806 812
25. J. Schonberger, J. Ruschoff, and D. Grimm Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study Thyroid 12 9 2002 747 754
26. R.S. Haber, K.R. Weiser, and A. Pritsker GLUT1 glucose transporter expression in benign and malignant thyroid nodules Thyroid 7 3 1997 363 367